GH1 and glomerular disorder: Regarding glomerulopathy, GH hypersecretion [77] or subcutaneous injections of GH (with the dose of 2 IU in the morning and 4 IU in the evening for one week) [93] and rhIGF-I (with the dose of 60 μg/kg, at 800, 1400 and 2000 h) [78] did not significantly alter albuminuria (as an index for glomerular permeability) and β2-microglobin (as an index for proximal tubular involvement).